European Medicines Agency Ema
- All
- News
- Videos
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
-
Two Vaccine Doses "Vital" Against Delta Variant Of Covid: European Regulator
The European Union's medicines watchdog said Wednesday two jabs by approved vaccine makers were "vital" to provide maximum protection against the highly-infectious coronavirus Delta variant, urging countries to speed up their inoculation drives.
-
Confident Europe Medicine Body Will Approve Covishield In A Month: Serum's Adar Poonawalla
Vaccine major Serum Institute of India (SII) is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's Chief Executive Officer Adar Poonawalla said today.
-
Clear Link Between AstraZeneca Vaccine, Rare Blood Clots In Brain: European Official
There is a link between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain but the possible causes are still unknown, a senior official for the European Medicines Agency (EMA) said in an interview published on Tuesday.
-
Why Some Countries Have Suspended The Use Of AstraZeneca Vaccine?
Why have several countries in Europe suspended use of the AstraZeneca vaccine, citing fears of blood clots, even as the European Union's top regulator insists there is no evidence of a link and calls for the inoculations to continue?
-
AstraZeneca Vaccine Approval Unlikely In January: European Union Agency
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
-
China, Russia Haven't Sought European Authorisation For Vaccines: Official
Russia and China have not requested authorisation from the European Medicines Agency (EMA) for their COVID-19 vaccines and the agency is not under political pressure to speed up vaccine approvals, the regulator's chief said in remarks published on Wednesday.
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
-
Two Vaccine Doses "Vital" Against Delta Variant Of Covid: European Regulator
The European Union's medicines watchdog said Wednesday two jabs by approved vaccine makers were "vital" to provide maximum protection against the highly-infectious coronavirus Delta variant, urging countries to speed up their inoculation drives.
-
Confident Europe Medicine Body Will Approve Covishield In A Month: Serum's Adar Poonawalla
Vaccine major Serum Institute of India (SII) is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's Chief Executive Officer Adar Poonawalla said today.
-
Clear Link Between AstraZeneca Vaccine, Rare Blood Clots In Brain: European Official
There is a link between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain but the possible causes are still unknown, a senior official for the European Medicines Agency (EMA) said in an interview published on Tuesday.
-
Why Some Countries Have Suspended The Use Of AstraZeneca Vaccine?
Why have several countries in Europe suspended use of the AstraZeneca vaccine, citing fears of blood clots, even as the European Union's top regulator insists there is no evidence of a link and calls for the inoculations to continue?
-
AstraZeneca Vaccine Approval Unlikely In January: European Union Agency
The coronavirus vaccine developed by AstraZeneca and Oxford University, which was approved Wednesday in Britain, is unlikely to get a green light in the European Union in the next month, according to the European Medicines Agency (EMA).
-
China, Russia Haven't Sought European Authorisation For Vaccines: Official
Russia and China have not requested authorisation from the European Medicines Agency (EMA) for their COVID-19 vaccines and the agency is not under political pressure to speed up vaccine approvals, the regulator's chief said in remarks published on Wednesday.
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
